Related references
Note: Only part of the references are listed.Human Hemato-Lymphoid System Mice: Current Use and Future Potential for Medicine
Anthony Rongvaux et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
Dennis Lindau et al.
IMMUNOLOGY (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
Alessandro Aiuti et al.
SCIENCE (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Alessandra Biffi et al.
SCIENCE (2013)
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
Bradley N. Bidwell et al.
NATURE MEDICINE (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling
Katherine Y. King et al.
BLOOD (2011)
Direct Effects of Type I Interferons on Cells of the Immune System
Sandra Hervas-Stubbs et al.
CLINICAL CANCER RESEARCH (2011)
Cancer Immunotherapy Comes of Age
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in
Armin Ehninger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Mark S. Diamond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Interferon: Current Status and Future Prospects in Cancer Therapy
Ben X. Wang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Interferon-α in acute myeloid leukemia: an old drug revisited
S. Anguille et al.
LEUKEMIA (2011)
A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1-derived lentiviral vectors
Gregory Berger et al.
NATURE PROTOCOLS (2011)
Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma
Frederick Lansigan et al.
DRUGS (2010)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
Marcin Kowanetz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification of Hematopoietic Stem Cell-Specific miRNAs Enables Gene Therapy of Globoid Cell Leukodystrophy
Bernhard Gentner et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer
Robert R. Jenq et al.
NATURE REVIEWS CANCER (2010)
IFNα activates dormant haematopoietic stem cells in vivo
Marieke A. G. Essers et al.
NATURE (2009)
ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling
Jochen C. Hartner et al.
NATURE IMMUNOLOGY (2009)
Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion
Taku Sato et al.
NATURE MEDICINE (2009)
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Nathalie Cartier et al.
SCIENCE (2009)
Tumor-targeted interferon-α delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis
Michele De Palma et al.
CANCER CELL (2008)
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis
Shusheng Wang et al.
DEVELOPMENTAL CELL (2008)
Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms
J-J Kiladjian et al.
LEUKEMIA (2008)
Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer
Mary Anna Venneri et al.
BLOOD (2007)
Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit
Sobha Kurian et al.
BREAST JOURNAL (2006)
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
F Ishikawa et al.
BLOOD (2005)
Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors
M De Palma et al.
CANCER CELL (2005)
A critical function for type I interferons in cancer immunoediting
GP Dunn et al.
NATURE IMMUNOLOGY (2005)
Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells
LD Shultz et al.
JOURNAL OF IMMUNOLOGY (2005)
Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells
M De Palma et al.
BLOOD (2005)
Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche
F Arai et al.
CELL (2004)
In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors
M De Palma et al.
HUMAN GENE THERAPY (2003)
Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells
M De Palma et al.
NATURE MEDICINE (2003)
Share Paper
